What is it about?
The study was performed at nine Japanese medical institutions for patients who had experienced an active CSC episode. Patients with CSC who received corticosteroids and had bilateral disease, chronic manifestation, non-intense fluorescein leakage on fluorescein angiography or a relatively thinner CRT should be closely monitored to identify whether they are at high risk of recurrence.
Photo by Bacila Vlad on Unsplash
Why is it important?
We herein integrated and analysed clinical and imaging data from a multicentre study to investigate the poten- tial risk factors for recurrence in patients with CSC. Increasing our awareness of the risk factors for recurrence of CSC has pivotal relevance for early detection, intensive treatment and promoting disease management.
Read the Original
This page is a summary of: A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy, Acta Ophthalmologica, May 2022, Wiley, DOI: 10.1111/aos.15194.
You can read the full text:
The following have contributed to this page